Answers are grounded in this paper and cite their sources.
Our FSP-ARKO mice not only provide the first in vivo evidence in Cre-loxP knockout system for the requirement of stromal fibroblast AR to maintain the normal development of the prostate, but may also suggest the selective knockdown of stromal AR might become a potential therapeutic approach to battle prostate hyperplasia and cancer.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: